Skip to main content

Advertisement

Log in

The Effects of Simvastatin on Ischemia Reperfusion Injury in an Experimental Colon Anastomosis Model

  • Original Article
  • Published:
Indian Journal of Surgery Aims and scope Submit manuscript

Abstract

Anastomotic leakage is more frequently reported in colonic anastomoses. Ischemia reperfusion injury is one of the main reasons for anastomotic leakage. Simvastatin is known to prevent tissue damage induced by free oxygen radicals after ischemia reperfusion injury. The effect of simvastatin on colonic anastomosis impaired by ischemia reperfusion injury is investigated. Single layer, end-to-end colocolic anastomosis after 0.5-cm colon resection was performed in Wistar Albino rats. In Group 1 (control) (n = 10), colonic anastomosis without I-R was performed. In Group 2 (n = 10), the superior mesenteric artery was clamped for 10 min followed by 60 min of reperfusion after which resection anastomosis was performed. In Group 3 (n = 10), 10 mg/kg simvastatin was given by gavage for 7 days after I-R and resection anastomosis. In Group 4 (n = 10), the rats received 10 mg/kg simvastatin by gavage 7 days before and 7 days after ischemia reperfusion and surgery. All of the rats were sacrificed 8 days after surgery. Anastomotic bursting pressure and tissue hydroxyproline levels were measured. Postoperative administration of simvastatin restored the anastomotic bursting pressure and hydroxyproline levels to that of control group thus overcoming the effect of ischemia reperfusion injury. Simvastatin administered postoperatively in an experimental model of colonic resection anastomosis impaired by ischemia reperfusion injury increased anastomotic bursting pressures and tissue hydroxyproline levels. Further experimental and clinical studies will show whether administration of simvastatin will increase reliability of the anastomosis and decrease postoperative morbidity and mortality in colonic anastomosis after ischemia reperfusion injury.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Soeters PB, de Zoete JP, Dejong CH, Williams NS, Baeten CG (2002) Colorectal surgery and anastomotic leakage. Dig Surg 19:150–155

    Article  CAS  PubMed  Google Scholar 

  2. Beck DE (2014) Colonic emergencies. In: Paterson-Brown S (ed) Core topics in general and emergency surgery, 5th edn. Saunders, Elsevier, Philadelphia, pp 179–203

    Google Scholar 

  3. Shogan BD, Carlisle EM, Alverdy JC, Umanskiy K (2013) Do we really know why colorectal anastomoses leak? J Gastrointest Surg 17:1698–1707. doi:10.1007/s11605-013-2227-0

    Article  PubMed  Google Scholar 

  4. Agren MS, Andersen TL, Mirastschijski U, Syk I, Schiødt CB, Surve V et al (2006) Action of matrix metalloproteinases at restricted sites in colon anastomosis repair: an immunohistochemical and biochemical study. Surgery 140:72–82

    Article  PubMed  Google Scholar 

  5. Shogan BD, Belogortseva N, Luong PM, Zaborin A, Lax S, Bethel C et al. (2015) Collagen degradation and MMP9 activation by Enterococcus faecalis contribute to intestinal anastomotic leak. Sci Transl Med 7:286ra68 doi: 10.1126/scitranslmed.3010658

  6. Siemionow M, Arslan E (2004) Ischemia/reperfusion injury: a review in relation to free tissue transfers. Microsurgery 24:468–475

    Article  PubMed  Google Scholar 

  7. Goszcz K, Deakin SJ, Duthie GG, Stewart D, Leslie SJ, Megson IL (2015) Antioxidants in cardiovascular therapy: panacea or false hope? Front Cardiovasc Med 6;2:29 doi: 10.3389/fcvm.2015.00029

  8. Johnson I, Spence MTZ (2010) The molecular probe handbook. A guide to fluorescent probes and labeling technologies. Life Technologies Corporation, Carlsbad, California

    Google Scholar 

  9. Maxwell SR, Lip GY (1997) Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options. Int J Cardiol 58:95–117

    Article  CAS  PubMed  Google Scholar 

  10. Grootjans J, Lenaerts K, Derikx JP, Matthijsen RA, de Bruïne AP, van Bijnen AA et al (2010) Human intestinal ischemia-reperfusion-induced inflammation characterized: experiences from a new translational model. Am J Pathol 176:2283–2291. doi:10.2353/ajpath.2010.091069

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Braskén P (1991) Healing of experimental colon anastomosis. Eur J Surg Supp 566:1–51

    Google Scholar 

  12. Czeiger D, Osyntsov A, Osyntsov L, Ball CG, Gigi R, Shaked G (2013) Examining the safety of colon anastomosis on a rat model of ischemia-reperfusion injury. World J Emerg Surg 8:24. doi:10.1186/1749-7922-8-24

    Article  PubMed  PubMed Central  Google Scholar 

  13. Kuzu MA, Köksoy C, Kale IT, Tanik A, Terzi C, Elhan AH (1998) Reperfusion injury delays healing of intestinal anastomosis in a rat. Am J Surg 176:348–351

    Article  CAS  PubMed  Google Scholar 

  14. Guzel S, Sunamak O, AS A, Celik V, Ferahman M, Nuri MM et al (2006) Effects of hyperbaric oxygen and Pgg-glucan on ischemic colon anastomosis. World J Gastroenterol 12:1421–1425

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Demiroğullari B, Sönmez K, Türkyilmaz Z, Ekingen G, Dursun A, Bor V et al (1998) Comparison of consequent small bowel anastomoses after transient ischemia: an experimental study in rats. J Pediatr Surg 33:91–93

    Article  PubMed  Google Scholar 

  16. Rugale C, Delbosc S, Mimran A, Jover B (2007) Simvastatin reverses target organ damage and oxidative stress in AngioTensin II hypertension: comparison with apocynin, tempol and hydralazine. J Cardiovasc Pharmacol 50:293–298

    Article  CAS  PubMed  Google Scholar 

  17. Karadeniz Cakmak G, Irkorucu O, Ucan BH, Emre AU, Bahadir B, Demirtas C et al (2009) Simvastatin improves wound strength after intestinal anastomosis in the rat. J Gastrointest Surg 13:1707–1716. doi:10.1007/s11605-009-0951-2

    Article  CAS  PubMed  Google Scholar 

  18. Rego AC, Araújo Filho I, Damasceno BP, Egito ES, Silveira IA, Brandão-Neto J et al (2007) Simvastatin improves the healing of infected skin wounds of rats. Acta Cir Bras 22(Suppl 1):57–63

    Article  PubMed  Google Scholar 

  19. Pruefer D, Makowski J, Schnell M, Buerke U, Dahm M, Oelert H et al (2002) Simvastatin inhibits inflammatory properties of Staphylococcus aureus alpha-toxin. Circulation 106:2104–2110

    Article  CAS  PubMed  Google Scholar 

  20. Calabrò P, Yeh ET (2005) The pleiotropic effects of statins. Curr Opin Cardiol 20:541–546

    Article  PubMed  Google Scholar 

  21. Blanco-Colio LM, Tuñón J, Martín-Ventura JL, Egido J (2003) Anti-inflammatory and immunomodulatory effects of statins. Kidney Int 63:12–23

    Article  CAS  PubMed  Google Scholar 

  22. Takenaka M, Hirade K, Tanabe K, Akamatsu S, Dohi S, Matsuno H et al (2003) Simvastatin stimulates VEGF release via p44/p42 MAP kinase in vascular smooth muscle cells. Biochem Biophys Res Commun 301:198–203

    Article  CAS  PubMed  Google Scholar 

  23. Ferri N, Colombo G, Ferrandi C, Raines EW, Levkau B, Corsini A (2007) Simvastatin reduces MMP1 expression in human smooth muscle cells cultured on polymerized collagen by inhibiting Rac1 activation. Arterioscler Thromb Vasc Biol 27:1043–1049. doi:10.1161/ATVBAHA.107.139881

    Article  CAS  PubMed  Google Scholar 

  24. Nomura S, Yoshimura K, Akiyama N, Mikamo A, Furutani A, Aoki H et al (2005) HMG-CoA reductase inhibitors reduce matrix metalloproteinase-9 activity in human varicose veins. Eur Surg Res 37:370–378. doi:10.1159/000090339

    Article  CAS  PubMed  Google Scholar 

  25. Demierre MF, Higgins PD, Gruber SB, Hawk E, Lippman SM (2005) Statins and cancer prevention. Nat Rev Cancer 5:930–942

    Article  CAS  PubMed  Google Scholar 

  26. Patrick L, Uzick M (2001) (2001) Cardiovascular disease: C-reactive protein and the inflammatory disease paradigm: HMG-CoA reductase inhibitors, alpha-tocopherol, red yeast rice, and olive oil polyphenols. A review of the literature. Altern Med Rev 6:248–271

    CAS  PubMed  Google Scholar 

  27. Kagami S, Kanari H, Suto A, Fujiwara M, Ikeda K, Hirose K et al (2008) HMG-CoA reductase inhibitor simvastatin inhibits proinflammatory cytokine production from murine mast cells. Int Arch Allergy Immunol 146(Suppl 1):61–66. doi:10.1159/000126063

    Article  CAS  PubMed  Google Scholar 

  28. Corsini A, Maggi FM, Catapano AL (1995) Pharmacology of competitive inhibitors of HMG-CoA reductase. Pharmacol Res 31:9–27

    Article  CAS  PubMed  Google Scholar 

  29. Liao JK, Laufs U (2005) Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 45:89–118

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Leung BP, Sattar N, Crilly A, Prach M, McCarey DW, Payne H et al (2003) A novel anti-inflammatory role for simvastatin in inflammatory arthritis. J Immunol 170:1524–1530

    Article  CAS  PubMed  Google Scholar 

  31. Solheim S, Seljeflot I, Arnesen H, Eritsland J, Eikvar L (2001) Reduced levels of TNF alpha in hypercholesterolemic individuals after treatment with pravastatin for 8 weeks. Atherosclerosis 157:411–415

    Article  CAS  PubMed  Google Scholar 

  32. Ferro D, Parrotto S, Basili S, Alessandri C, Violi F (2000) Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia. J Am Coll Cardiol 36:427–431

    Article  CAS  PubMed  Google Scholar 

  33. Lefer DJ (2002) Statins as potent antiinflammatory drugs. Circulation 106:2041–2042

    Article  PubMed  Google Scholar 

  34. Malyszko J, Malyszko JS, Hryszko T, Mysliwiec M (2003) Influence of simvastatin on aspects of thrombogenesis in CAPD patients. Perit Dial Int 23:260–266

    CAS  PubMed  Google Scholar 

  35. Undas A, Brummel-Ziedins KE, Mann KG (2005) Statins and blood coagulation. Arterioscler Thromb Vasc Biol 25:287–294

    Article  CAS  PubMed  Google Scholar 

  36. Schmidt WM, Spiel AO, Jilma B, Wolzt M, Müller M (2008) In-vivo effects of simvastatin and rosuvastatin on global gene expression in peripheral blood leucocytes in a human inflammation model. Pharmacogenet Genomics 18:109–120. doi:10.1097/FPC.0b013e3282f44d81

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kuzey Aydinuraz.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Akarsu, M., Saygun, O., Aydinuraz, K. et al. The Effects of Simvastatin on Ischemia Reperfusion Injury in an Experimental Colon Anastomosis Model. Indian J Surg 79, 390–395 (2017). https://doi.org/10.1007/s12262-016-1493-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12262-016-1493-y

Keywords

Navigation